SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 77 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $35,000 | -58.8% | 15,766 | -63.8% | 0.00% | -66.7% |
Q1 2015 | $85,000 | -49.1% | 43,591 | -30.9% | 0.00% | -50.0% |
Q4 2014 | $167,000 | -30.7% | 63,123 | -21.0% | 0.01% | -14.3% |
Q3 2014 | $241,000 | -31.3% | 79,927 | -7.0% | 0.01% | -22.2% |
Q2 2014 | $351,000 | +663.0% | 85,937 | +703.0% | 0.01% | +800.0% |
Q1 2014 | $46,000 | -47.7% | 10,702 | -36.3% | 0.00% | -66.7% |
Q4 2013 | $88,000 | +31.3% | 16,802 | +58.5% | 0.00% | +50.0% |
Q3 2013 | $67,000 | – | 10,601 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 28,639,349 | $123,436,000 | 94.21% |
Verity Asset Management, Inc. | 103,021 | $456,000 | 0.47% |
NBW CAPITAL LLC | 242,153 | $1,044,000 | 0.27% |
Old West Investment Management, LLC | 69,997 | $301,000 | 0.19% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 196,639 | $848,000 | 0.12% |
SOPHROSYNE CAPITAL LLC | 25,700 | $111,000 | 0.10% |
Cutler Capital Management, LLC | 45,000 | $194,000 | 0.08% |
Rotella Capital Management, Inc. | 11,700 | $50,000 | 0.06% |
STONERIDGE INVESTMENT PARTNERS LLC | 66,397 | $286,000 | 0.06% |
Roundview Capital LLC | 21,100 | $91,000 | 0.04% |